Pharmaceutical Business review

Merck Acquires Suzhou Taizhu Technology Development Co.

Germany-based Merck has acquired Suzhou Taizhu Technology Development Co. (Taizhu), a supplier of effect pigments located in Taicang near Shanghai, China. The acquisition is said to of high strategic importance to the Merck pigments business.

Within the scope of this transaction, Merck has acquired the production site of Taizhu in Taicang, 40 km from Shanghai, and the entire sales and marketing organisation in China and abroad for a total consideration of E28m.

Klaus Bischoff, head of the performance & life science chemicals division at Merck, said: “The transaction is highly attractive for Merck because Taizhu’s products complement our premium product portfolio with a range that mainly serves the growing value-for-money market segment. In addition, Taizhu’s customer base ideally complements our own. In recent years, Taizhu has built an outstanding reputation as a reliable source of high-quality effect pigments.”